Use and outcomes of hormonal therapy for advanced-stage, low-grade serous ovarian cancer.
Yoh K, Chen L, Xu X, Ferris JS, Dioun S, Buckley de Meritens A, St Clair CM, Pua T, Randall T, Hou JY, Hershman DL, Wright JD.
Yoh K, et al. Among authors: ferris js.
Int J Gynecol Cancer. 2025 Dec;35(12):102676. doi: 10.1016/j.ijgc.2025.102676. Epub 2025 Sep 20.
Int J Gynecol Cancer. 2025.
PMID: 41086655